Skip to content

Neuromodulation on Post-stroke Patients: A Clinical Control Trial based on Mapping Swallowing Musculature Motor Cortex

Neuromodulation on Post-stroke Patients: A Clinical Control Trial based on Mapping Swallowing Musculature Motor Cortex

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17011673
Enrollment
Unknown
Registered
2017-06-16
Start date
2017-06-26
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke Dysphagia

Interventions

conditional control group:sham TMS
healthy group:none

Sponsors

Guangzhou First People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Healthy Group: 1. Have signed the informed consent; 2. Aged 18~25 years; 3. no history of neurological or psychiatric diseases; 4. no history of swallowing problems nor medical conditions that would contribute to dysphagia; 5. Reported right-handed according to Edinburgh Handedness Inventory. Patients' Group: 1. Have signed the informed consent; 2. Aged 18~75 years; 3. Had unilateral hemispheric stroke or brainstem stroke confirmed by MRI; 4. Determined as Oropharyngeal dysphagia or pharyngeal dysphagia according to VFSS; 5. score >17 on MMSE, be able to cooperate; 6. Be in general good health, without severe function failure.

Exclusion criteria

Exclusion criteria: Healthy Group: 1. history of esophageal disease; 2. Pregnant; 3. having contraindications to receiving TMS,including metel implants, brain tumor and intracranial hypertension. Patients' Group: 1. with severe psychiatric diseases; 2. dysphagia contributed by other neurological diseases or head and neck neoplasms; 3. already have swallowing problems before this onset; 4. Pregnant; 5. having contraindications to receiving TMS,including metal implants, brain tumor and intracranial hypertension.

Design outcomes

Primary

MeasureTime frame
pharyngeal musculature motor evoked potential;MEP Amplitude;latency ofMEP;Hotspot;

Countries

China

Contacts

Public ContactYue Lan

Guangzhou First People's Hospital

blumooning@163.com+86 18988991916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026